Immune Complex Specific for the Pancreatic Duct Antigen in Patients with Idiopathic Chronic Pancreatitis and Sjögren Syndrome

References

• Watts R. A., Isenberg D. A. Pancreatic disease in the autoimmune rheumatic disorders. Semin. Arthritis Rheum. 1989; 19: 158–165
   PubMedGoogle Scholar
• Epstein O., Chapman R. W.G., Lake-Bakaar G., Foo A. Y., Rosalki S. B., Sherlock S. The pancreas in primary biliary cirrhosis and primary sclerosing cholangitis. Gastroenterology 1982; 83: 1177–1182
   PubMed Web of Science ®Google Scholar
• Fonseca V., Epstein O., Katrak A., Junglee D., Mikhailidis D. P., McIntyre N., et al. Serum immunoreactive trypsin and pancreatic lipase in primary biliary cirrhosis. J Clin. Pathol. 1986; 39: 638–640
   PubMedGoogle Scholar
• Dreiling D. A., Soto J. M. The pancreatic involvement in disseminated “collagen” disorders. Am. J. Gastroenterol. 1976; 66: 546–553
   PubMed Web of Science ®Google Scholar
• Gohelet C., Gerster J. C., Pappoport G., Hiroz C. A., Maeder E. A controlled study of the exocrine pancreatic function in Sjögren's syndrome and rheumatoid arthritis. Clin. Rheumatol. 1983; 2: 139–143
   PubMedGoogle Scholar
• Coll J., Navarro S., Tomas R., Elena M., Martinez E. Exocrine pancreatic function in Sjogren's syndrome. Arch. Intern. Med. 1989; 149: 848–852
   PubMedGoogle Scholar
• Fonkalsrud E. W., Longmire W. P. The occurrence of pancreatic antibodies and the experimental production of pancreatitis with pancreatic antiserum. Surgery 1961; 50: 134–142
   PubMed Web of Science ®Google Scholar
• Dani R., Antunes L. J., Ribeiro J. E.F., Nogueira C. E.D., Ribeiro T. Immunological participation in chronic calcifying pancreatitis. Digestion 1974; 11: 333–337
   PubMed Web of Science ®Google Scholar
• Schutt C., Friemel H., Schulze H. A., Zubaidi G. Specific lymphocyte sensitization in chronic pancreatitis. Digestion 1975; 13: 308–311
   PubMedGoogle Scholar
• Antal L., Kavai M., Szabo G., Sonkoly I., Paloczi K., Szegedi G., et al. Immunological investigations in acute and chronic human pancreatitis. Digestion 1980; 20: 100–105
   PubMed Web of Science ®Google Scholar
• Bovo P., Mirakian R., Merigo F., Angelini G., Gavallini G., Rizzini P., Bottazzo G. F., Scuro L. A. HLA molecule expression on chronic pancreatitis specimens: Is there a role for autoimmunity? A preliminary study. Pancreas 1987; 2: 350–356
   PubMedGoogle Scholar
• Bardana E. J., Harbeck R. J., Hoffman A. A., Pirofsky B., Carr R. I. The prognostic and therapeutic implications of DNA: anti-DNA immune complexes in systemic lupus erythematosus (SLE). Am. J. Med. 1975; 59: 515–522
   PubMedGoogle Scholar
• Mumford P. A., Horsfall A. C., Maini R. N. The frequency of CIC in RA and SLE. A comparative study using three assay systems. Rheumatol. Int. 1982; 1: 181–186
   Google Scholar
• Aguado M. T., Lambris J. D., Tsokos G. C., Burger R., Bitter-Suermann D., Tamerius J. D., et al. Monoclonal antibodies against complcment factor C3 neoantigens for detection of immune complexes and complement activation. J. Clin. Invest. 1985; 76: 1418–1426
   PubMed Web of Science ®Google Scholar
• Nilsson B., Bjelle A., Loof L., Nilsson U. R. Quantitation and antigenic characterization of bound C3 of circulating immune complexes in systemic lupus erythematosus, rheumatoid arthritis, and primary biliary cirrhosis. J. Clin. Immunol. 1987; 7: 420–426
   PubMedGoogle Scholar
• Gupta R. C., Simpson W. A., Raghow R. Interaction of fibronectin with DNA/anti-DNA complexes from systemic lupus erythematosus: role of activated complement CI in modulation of the interactions. Clin. Immunol. Immunopathol. 1988; 46: 368–381
   PubMedGoogle Scholar
• Huber G, Ruger A., Herrmann M., Krapf F., Kalden J. R. C3-containing serum immune complexes in patients with systemic lupus erythematosus: correlation to disease activity and comparison with other rheumatic disease. Rheumatol. Int. 1989; 9: 59–64
   PubMedGoogle Scholar
• Okazdki K., Tamura S., Morita M., Nishimori I., Yamamoto Y., Yamamoto Y. Interspecies crossreactive antigen of the pancreatic duct cell prepared by monoclonal antibody. Int. J. Pancreatol. 1989; 5: 359–377
   PubMedGoogle Scholar
• Nishimori I., Okazaki K., Yamamoto Y., Morita M., Tamura S., Yamamoto Y. Specific cellular immune responses to pancreatic antigen in chronic pancreatitis and Sjogren's syndrome. J. Clin. Immunol. 1993; 13: 265–271
   PubMedGoogle Scholar
• Nishimori I., Yamamoto Y., Okazaki K., Morita M., Onodera M., Kino J. Identification of autoantibodies to a pancreatic antigen in patients with idiopathic chronic pancreatitis and Sjogren's syndrome. Pancreas 1994; 9: 374–381
   PubMedGoogle Scholar
• Theofilopoulos A. N. Evaluation and clinical significance of circulating immune complexes. Prog. Clin. Immunol. 1980; 4: 63–106
   PubMedGoogle Scholar
• Theofilopoulos A. N., Wilson C. B., Dixon F. J. The Raji cell radioimmune assay for detecting immune complexes in human sera. J. Clin. Invest. 1976; 51: 169–182
   Google Scholar
• Feltkamp T. E.W., Rossum A. L. Antibodies to salivary duct cells, and other idiopathic autoimmune discase. Clin. Exp. Immunol. 1968; 3: 1–16
   PubMedGoogle Scholar
• Whaley K., Chisholm D. M., Goudie R. B., Downie W. W., Dick W. C., Boyle J. A., et al. Salivary duct autoantibody in Sjögren's syndrome: Correlation with focal sialadenitis in the labial mucosa. Clin. Exp. Immunol. 1969; 4: 273–282
   Google Scholar
• Anderson L. G., Tarpley T. M., Talal N., Cummings N. A., Wolf R. O., Schall G. L. Cellular-versus-humoral autoimmune responses to salivary gland in Sjögren's syndrome. Clin. Exp. Immunol. 1973; 13: 335–342
   PubMed Web of Science ®Google Scholar
• Berry H., Bacon P. A., Davis J. D. Cell-mediated immunity in Sjögren's syndrome. Ann. Rheum. Dis. 1972; 31: 298–302
   PubMed Web of Science ®Google Scholar
• McFarlane I. G., Wojcicka B. M., Tsantoulas D. C., Funk C., Portmann B., Eddlcston A. L.W.F., et al. Cellular immune responses to salivary antigens in autoimmune liver disease with sicca syndrome. Clin. Exp. Immunol. 1976; 25: 389–395
   PubMedGoogle Scholar
• Ludwig H., Schernthaner G., Schcrak O., Kolarz G. Antibodies to pancreatic duct cells in Sjogren's syndrome and rheumatoid arthritis. Gut. 1977; 18: 311–315
   PubMed Web of Science ®Google Scholar
• Sundkvist G., Lindahl G., Koskinen P., Bolinder J. Pancreatic autoantibodies and pancreatic function in Sjogren's syndrome. J. Intern. Med. 1991; 229: 61–66
   PubMed Web of Science ®Google Scholar
• Haspel M. V., Onodera T., Prabhakar B. S., McClintock P. R., Essani K., Ray U. R., et al. Multiple organ-reactivc monoclonal autoantibodies. Nature 1983; 304: 73–76
   PubMed Web of Science ®Google Scholar
• Strand V., Talal N. Advances in the diagnosis and Concept of Sjögren's syndrome (autoimmune exocrinopathy). Bull. Rheum. Dis. 1980; 30: 1046–1052
   Google Scholar
• Williams R. C., Jr. Immune complexes in human disease. Annu. Rev. Med. 1981; 32: 13–28
   PubMedGoogle Scholar
• Davis P., Cumming R. H., Verrier-Jones J. Relationship between anti-DNA antibodies, complement consumption and circulating immune complexes in systemic lupus erythematosus. Clin. Exp. Immunol. 1977; 28: 226–232
   PubMed Web of Science ®Google Scholar
• Pussell B. A., Lockwood C. M., Scott D. M., Pinching A. J., Peters D. K. Value of immune complex assays in diagnosis and management. Lancet 1978; 2: 359–364
   PubMedGoogle Scholar
• IUIS/WHO working group. Use and abuse of laboratory tests in clinical immunology: critical considerations of eight widely used diagnostic procedures. Clin. Exp. Immunol. 1981; 46: 662–674
   Google Scholar
• Horsfall A. C., Venables P. J.W., Mumford P. A., Maini R. N. Interpretation of the Raji cell assay in sera containing anti-nuclear antibodies and immune complexes. Clin. Exp. Immunol. 1981; 44: 405–415
   PubMedGoogle Scholar
• Wands J. R., Dienstag J. L., Bhan A. K., Feller E. R., Isselbacher K. J. Circulating immune complexes and complement activation in primary biliary cirrhosis. N. Engl. J. Med. 1978; 298: 233–237
   PubMed Web of Science ®Google Scholar
• Epstein O., De Villiers D., Jain S., Potter B. J., Thomas H. C., Sherlock S. Reduction of immune complexes and immunoglobulins induced by D-penicilamine in primary biliary cirrhosis. N. Engl. J. Med. 1979; 300: 274–278
   PubMedGoogle Scholar
• Gupta R. C., Dickson E. R., McDuffie E. C., Bagenstoss A. H. Circulating IgG complexes in primary biliary cirrhosis. A serial study in forty patients followed for two years. Clin. Exp. Immunol. 1978; 34: 19–27
   PubMed Web of Science ®Google Scholar
• Amoroso P., Vergani D., Wojcicka B. M., McFarlane I. G., Eddleston A. L.W.F., Tec D. E.H., et al. Identification of biliary antigens in circulating immune complexes in primary biliary cirrhosis. Clin. Exp. Immunol. 1980; 42: 95–98
   PubMedGoogle Scholar
• Goldberg M. J., Kaplan M. M., Mitamura T., Anderson C. L., Matloff D. S., Pinn V. W., et al. Evidence against an immune complex pathogenesis of primary biliary cirrhosis. Gastroenterology 1982; 83: 677–683
   PubMedGoogle Scholar
• Bendaoud B., Pennec Y. L., Lelong A., Le Noac'h J. F., Magadur G., Jouquan J., et al. IgA-containing immune complexcs in the circulation of patients with primary Sjögren's syndrome. J Autoimmun 1991; 4: 177–184
   PubMed Web of Science ®Google Scholar
• Oxholm P., Oxholm A., Thomsen B. S., Braathen L. Epidermal cell surface-associated IgG in patients with primary Sjögren's syndrome: in vitro evidence for immune complex binding. Arch. Dermatol. Res. 1990; 282: 423–427
   PubMedGoogle Scholar
• Bialasiewicz A. A., Naumann G. O. Tectonic keratoplasty in perforated corneal ulcer in Sjögren's syndrome (report of 10 eyes in 8 patients). Klin. Monatsbl. Augenheilkd. 1988; 193: 554–564
   PubMedGoogle Scholar
• Jancar S., De Giaccobi G., Mariano M., Mencia-Huerta J. M., Sirois P., Branquet P. Immune complex induced pancreatitis: effect of BN 52021, a selective antagonist of platelet-activating factor. Prostaglandins. 1988; 35: 757–770
   PubMedGoogle Scholar